gip glp 1 drugs GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Tirzepatide's Unique Mechanism of Action

I'm saying the conversation should start with the science and not end with fear

Mathian A, Felten R, Alarcon-Riquelme ME, Psarras A, Mertz P, Chasset F, et al

Addressing other modifiable lifestyle factors and environmental interventions, such as more time in nature, a reduction in exposure to artificial light, and improving indoor air quality, have demonstrated promise

Peptide bond formation requires amino acid with an amino group (NH2) at the N-terminal, a carboxyl group (COOH) at the C-terminal, and a unique side chain (R)

This chemistry has been used to develop pH-sensitive phospholipids for drug and gene delivery